U.S. FDA delays decision on Juul e-cigarettes

FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly

(Reuters) – The U.S. Food and Drug Administration said on Thursday it needs more time to decide whether e-cigarette maker Juul Labs Inc and other major manufacturers can sell their products in the United States.

The agency had been expected to make a decision by Thursday, a year after Juul and other e-cigarette brands, including British American Tobacco Plc’s Vuse and Imperial Brands Plc’s Blu, faced a deadline to file applications showing their products provided a net benefit to public health.

The agency said on Thursday that it continues to “work expeditiously on the remaining applications,” adding many are “in the final stages of review.”

Source: Read Full Article

Related posts:
  1. Novo Nordisk's semaglutide gets U.S. FDA approval for obesity treatment
  2. Report reveals Mississippi leads the pack of 'fattest' US states
  3. Mexico reports 7,030 new coronavirus cases, 462 more deaths
  4. Biden to send 20 million doses of U.S.-authorized vaccines abroad for first time
  5. Four more Brazilian states deemed free of foot-and-mouth disease – AgMin